View
4
Download
0
Category
Preview:
Citation preview
Evaluation of CHROMagar Acinetobacter for the Detection of Enteric Carriage 1
of Multi-drug Resistant Acinetobacter baumannii in Critically Ill Patients 2
3
N C Gordon1, D W Wareham1,2* 4
5
1Division of Infection, Barts & The London NHS Trust, London, UK 6
2Centre for Infectious Disease, Institute of Cell and Molecular Science, Barts & The 7
London School of Medicine and Dentistry, Queen Mary University of London, 8
London, UK 9
10
11
*Corresponding author 12
Dr D Wareham 13
Centre for Infectious Disease, 14
Institute of Cell and Molecular Science 15
4 Newark Street 16
Whitechapel 17
London E1 2AT 18
19
Tel: +44(0)20 7882 2317 Fax: +44(0)20 7882 2181 20
Email: d.w.wareham@qmul.ac.uk 21
22
Running title: CHROMagar Acinetobacter 23
24
25
Copyright © 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.J. Clin. Microbiol. doi:10.1128/JCM.00634-09 JCM Accepts, published online ahead of print on 13 May 2009
on March 13, 2020 by guest
http://jcm.asm
.org/D
ownloaded from
Abstract 26
CHROMagar Acinetobacter was used to screen stool and perineal swabs for enteric 27
carriage of multi-drug resistant A. baumannii in critically ill patients. Results were 28
compared with a molecular assay resulting in a sensitivity and specificity of culture 29
compared to PCR of 91.7% and 89.6% respectively. 30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
on March 13, 2020 by guest
http://jcm.asm
.org/D
ownloaded from
Acinetobacter baumannii has emerged as an important nosocomial pathogen, 50
impacting considerably on patient care (6, 9). In many parts of the world, strains 51
resistant to almost all available antimicrobial classes (multidrug-resistant 52
Acinetobacter baumannii, MDRAB) have been reported and implicated in numerous 53
hospital outbreaks, usually in intensive therapy units (ITU) (2). Despite the 54
implementation of infection control measures involving isolation of patients, rigorous 55
hand hygiene and aggressive environmental decontamination, many centers have 56
continued to have ongoing problems, with rapid re-emergence of the organism 57
unless high standards of cleaning are maintained (4, 10). 58
59
Although environmental cleaning is of paramount importance, it is likely that patients 60
themselves also represent a significant reservoir of the organism. For many Gram-61
negative bacteria colonization of the digestive tract is an important pre-requisite for 62
the development of nosocomial infections such as ventilator-associated pneumonia 63
(3, 7). Rapid identification of individuals with enteric carriage of MDRAB could 64
therefore be an important component in strategies aimed at limiting the transmission 65
and dissemination of the organism. 66
67
CHROMagar Acinetobacter (CHROMagar, Paris, France) is a recently developed 68
selective agar for the rapid identification of MDRAB. It contains agents which inhibit 69
the growth of most Gram-positive organisms as well as carbapenem susceptible 70
Gram-negative bacilli. It incorporates substrates enabling color based preliminary 71
identification of colonies recovered within 18-24 hours of inoculation. In this study we 72
evaluated the ability of CHROMagar Acinetobacter to detect the carriage of MDRAB 73
on March 13, 2020 by guest
http://jcm.asm
.org/D
ownloaded from
in enteric samples from critically ill patients in a unit experiencing problems with 74
MDRAB, compared with a molecular method. 75
76
CHROMagar Acinetobacter was prepared from dehydrated powder according to the 77
manufacturer’s instructions. Each batch of media was quality controlled using a 78
representative isolate of the MDRAB OXA-23 clone-1, obtained from the Health 79
Protection Agency, Colindale, UK, previously characterized as resistant to 80
carbapenems (2). Stool samples and / or perineal swabs collected from ITU patients 81
as part of routine screening for Clostridium difficile associated diarrhea or meticillin 82
resistant Staphylococcus aureus (MRSA) carriage were used to inoculate 83
CHROMagar Acinetobacter plates and then 3 ml peptone water broths. Plates were 84
incubated in air at 37 °C and examined after 24 hours for aqua blue colonies 85
indicative of MDRAB (figure 1). The peptone broths were also incubated for 24 hours 86
and used to generate templates for a MDRAB specific molecular assay. 100 µl of 87
turbid broth was heated at 96 °C for 5 min and then centrifuged at 13, 000 rpm to 88
pellet lysed bacterial cells. 2 µl of supernatant was used in a multiplex PCR for the A. 89
baumannii species specific OXA-51-like gene and the OXA-23, -24 and -58-like 90
genes, which mediate carbapenem resistance, using the primers and conditions 91
described by Woodford et al (11). Isolates presumed to be A. baumannii based on 92
their growth and appearance on CHROMagar Acinetobacter were confirmed as such 93
by Gram staining, oxidase testing and multiplex PCR assay. The clonal lineage of 94
each isolate was also determined using another multiplex PCR assay, based on 95
sequence variations in the csuE, ompA and blaOXA-51 alleles. This enables strains to 96
be assigned to clonal complexes with a reliability equivalent to that obtained using 97
pulsed field gel electrophoresis (8). 98
on March 13, 2020 by guest
http://jcm.asm
.org/D
ownloaded from
Sixty-six stool samples and 37 perineal swabs obtained from a total of 70 patients 99
were ultimately included in the analysis. Thirty-three of these were positive by both 100
culture and PCR on peptone broths (table 1). Seven were culture positive but PCR 101
negative whilst 3 were found to be culture negative yet positive by PCR. The gene 102
profiles detected in the PCR assay were identical in every case: OXA-51 +ve, OXA-103
23 +ve, OXA-24 –ve, OXA-58 –ve. 104
105
Biochemical and molecular testing of colonies identified as MDRAB using 106
CHROMagar Acinetobacter confirmed that all of the organisms were A. baumannii 107
resistant to β-lactams (including carbapenems), quinolones and aminoglycosides. 108
Multiplex PCR typing placed them as members of European clone II. The only other 109
organisms recovered from samples inoculated onto CHROMagar Acinetobacter were 110
Enterococcus spp which were easily distinguishable by their dark blue color and 111
small colonial morphology. 112
113
Of the 40 patients with positive MDRAB cultures, 33 were known to be colonized at 114
other sites. In 7 patients MDRAB was isolated from stool alone and not from any 115
other clinical specimens. The sensitivity and specificity of culture compared with the 116
PCR assay were calculated as 91.7% and 89.6% respectively. 117
118
For the 7 samples found to be culture positive using CHROMagar Acinetobacter, but 119
negative in PCRs performed on peptone broths, follow up testing of the colonies 120
confirmed that these were all MDRAB. In 6 of these the patients had already had 121
MDRAB isolated from other clinical specimens. As the broths were inoculated after 122
the CHROMagar plates it is possible that either insufficient material remained on the 123
on March 13, 2020 by guest
http://jcm.asm
.org/D
ownloaded from
swabs or, in the case of the stool samples, there may have been significant inhibition 124
of the PCR reaction. 125
126
Our findings support the use of CHROMagar Acinetobacter as a means of identifying 127
enteric carriage of MDRAB, but are limited by the relatively small numbers and the 128
involvement of a single MDRAB clone. Also, as the stool samples were those sent 129
for C. difficile testing, only semi-formed or liquid stools were obtained. The use of the 130
media with formed stools would therefore require further evaluation. A comparison 131
between stool and perineal swab cultures would also help to determine whether 132
perineal swabs can be used as a proxy marker of gut carriage. These are easier to 133
process and are already routinely obtained to screen for other nosocomial pathogens 134
in many clinical settings. 135
136
The study also highlights a role for the gut as a significant reservoir for MRAB in 137
addition to environmental contamination. It raises the question of whether selective 138
decontamination of the digestive tract (SDD) using non-absorbable antibiotics such 139
as polymyxin B, to which MDRAB remain susceptible, could be a suitable method of 140
control. The SDD approach has been shown to be effective in reducing the carriage 141
and incidence of nosocomial infections caused by Gram-negative bacteria but has 142
not been widely adopted (1, 5). The availability of a selective culture media such as 143
CHROMagar Acinetobacter, enabling those who may benefit from such a regimen to 144
be rapidly identified, is clearly an important step towards addressing this issue. 145
146
147
148
on March 13, 2020 by guest
http://jcm.asm
.org/D
ownloaded from
Acknowledgments 149
This study was presented in part at the 19th European Congress of Clinical 150
Microbiology and Infectious Diseases, Helsinki, Finland. May, 2009 151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
on March 13, 2020 by guest
http://jcm.asm
.org/D
ownloaded from
References 174
175
1. Agustí C., M. Pujol, M. J. Argerich, J. Ayats, M. Badía, M. A. Domínguez, X. 176
Corbella, and J. Ariza. 2002. Short-term effect of the application of selective 177
decontamination of the digestive tract on different body site reservoir ICU patients 178
colonized by multi-resistant Acinetobacter baumannii. J Antimicrob Chemother. 179
49:205-8. 180
181
2. Coelho J. M., J. F. Turton, M. E. Kaufmann, J. Glover, N. Woodford, M. 182
Warner, M. F. Palepou, R. Pike, T. L. Pitt, B. C. Patel, and D. M. Livermore. 2006. 183
Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple 184
hospitals in London and Southeast England. J Clin Microbiol. 44:3623-7. 185
186
3. Corbella X., M. Pujol, J. Ayats, M. Sendra, C. Ardanuy, M. A. Domínguez, J. 187
Liñares, J. Ariza, and F. Gudiol. 1996. Relevance of digestive tract colonization in 188
the epidemiology of nosocomial infections due to multiresistant Acinetobacter 189
baumannii. Clin Infect Dis. 23:329-34 190
191
4. Denton M., M. H. Wilcox, P. Parnell, D. Green, V. Keer, P. M. Hawkey, I. 192
Evans, and P. Murphy. 2004. Role of environmental cleaning in controlling an 193
outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit. J Hosp 194
Infect. 56:106-10. 195
196
on March 13, 2020 by guest
http://jcm.asm
.org/D
ownloaded from
5.De Smet A. M., J. A. Kluytmans, B. S. Cooper, E. M. Mascini, R. F. Benus, T. 197
S. van der Werf, J. G. van der Hoeven, P. Pickkers, D. Bogaers-Hofman, N. J. 198
van der Meer , A. T. Bernards, E. J. Kuijper, J. C. Joore, M. A. Leverstein-van 199
Hall, A. J. Bindels, A. R. Jansz, R. M. Wesselink, B. M. de Jongh, P. J. 200
Dennesen, G. J. van Asselt, L. F. te Velde, I. H. Frenay, K. Kaasjager, F. H. 201
Bosch, M. van Iterson, S. F. Thijsen, G. H. Kluge, W. Pauw , J. W. de Vries, J. 202
A. Kaan, J. P. Arends, L. P. Aarts, P. D. Sturm, H. I. Harinck, A. Voss, E. V. 203
Uijtendaal, H. E. Blok, E. S. Thieme Groen, M. E. Pouw, C. J. Kalkman, and M. J. 204
Bonten. 2009. Decontamination of the digestive tract and oropharynx in ICU 205
patients. N Engl J Med. 360:20-31. 206
207
6. Maragakis, L. L. and T. M. Perl. 2008. Acinetobacter baumannii: epidemiology, 208
antimicrobial resistance, and treatment options. Clin Infect Dis. 15:1254-63 209
210
7. Silvestri L., H. K. van Saene, A. Casarin, G. Berlot , and A. Gullo. 2008. 211
Impact of selective decontamination of the digestive tract on carriage and infection 212
due to Gram-negative and Gram-positive bacteria: a systematic review of 213
randomised controlled trials. Anaesth Intensive Care. 36:324-38. 214
215
8. Turton J. F., S. N. Gabriel, C. Valderrey, M. E. Kaufmann, and T. L. Pitt. 2007. 216
Use of sequence-based typing and multiplex PCR to identify clonal lineages of 217
outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect. 13:807-15. 218
219
on March 13, 2020 by guest
http://jcm.asm
.org/D
ownloaded from
9. Wareham D. W., D. C. Bean, P. Khanna, E. M. Hennessey, D. Krahe, E. Ely 220
and M. Millar. 2008. Bloodstream infection due to Acinetobacter spp: epidemiology, 221
risk factors and impact of multi-drug resistance. Eur J Clin Microbiol Infect Dis. 222
27:607-12. 223
224
10. Wilks M., A. Wilson, S. Warwick, E. Price, D. Kennedy, A. Ely, and M. R. 225
Millar. 2006. Control of an outbreak of multidrug-resistant Acinetobacter baumannii-226
calcoaceticus colonization and infection in an intensive care unit (ICU) without 227
closing the ICU or placing patients in isolation. Infect Control Hosp Epidemiol. 228
27:654-8. 229
230
11. Woodford N., M. J. Ellington, J. M. Coelho, J. F. Turton, M. E. Ward, S. 231
Brown, S. G. Amyes, and D. M. Livermore. 2006. Multiplex PCR for genes 232
encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antomicrob 233
Agents. 27:351-3 234
235
236
237
238
239
240
241
242
243
244
on March 13, 2020 by guest
http://jcm.asm
.org/D
ownloaded from
Figure 1. Appearance on MDRAB on CHROMagar Acinetobacter plates 245
246
247
248
249
250
251
252
253
254
255
256
257
258
on March 13, 2020 by guest
http://jcm.asm
.org/D
ownloaded from
Table 1: Comparison of culture and molecular tests for the identification of MDRAB 259
260
Culture PCR No. of specimens Known Colonized
Negative Negative 60 20
Positive Positive 33 28
Positive Negative 7 6
Negative Positive 3 1
Total 103 55
261
on March 13, 2020 by guest
http://jcm.asm
.org/D
ownloaded from
Recommended